Evaluation of phenotypic screening tests for carbapenemase production in Pseudomonas aeruginosa from patients with cystic fibrosis

Journal of Microbiological Methods

Volumn 111, Issue , 2015, Pages 105-107

  Tai, Anna S ^a,b   Sidjabat, Hanna E ^c   Kidd, Timothy J ^a   Whiley, David M ^a   Paterson, David L ^c   Bell, Scott C ^a,b,d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Carba NP test; Cystic fibrosis; Metallo lactamase; Modified Hodge test; PCR; Pseudomonas aeruginosa

Indexed keywords

CARBAPENEMASE; MEROPENEM; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BIOSYNTHESIS; CARBA NP TEST; COMBINED DISC TEST; CYSTIC FIBROSIS; DOUBLE DISC SYNERGY TEST; ENZYME ASSAY; ENZYME SYNTHESIS; FALSE POSITIVE RESULT; HUMAN; INTERMETHOD COMPARISON; METALLO BETA LACTAMASE TEST; MODIFIED HODGE TEST; NONHUMAN; PHENOTYPE; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; SCREENING TEST; COMPLICATION; DRUG EFFECTS; ENZYMOLOGY; EVALUATION STUDY; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; POLYMERASE CHAIN REACTION; PSEUDOMONAS INFECTION;

PSEUDOMONAS AERUGINOSA;

BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAMASES; CYSTIC FIBROSIS; FALSE POSITIVE REACTIONS; HUMANS; PHENOTYPE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84922725255     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2015.02.006     Document Type: Article

References (30)

1. Cardoso O., Alves A.F., Leitao R. Metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from a cystic fibrosis patient. Int. J. Antimicrob. Agents 2008, 31:375-379.
2. CLSI Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. CLSI document M100-S23 2013, Clinical and Laboratory Standards Institute, Wayne, Pennsylvania.
3. Dortet L., Poirel L., Nordmann P. Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test. Antimicrob. Agents Chemother. 2012, 56:6437-6440.
4. Dortet L., Brechard L., Poirel L., Nordmann P. Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test. J. Med. Microbiol. 2014, 63:772-776.
5. Dortet L., Poirel L., Nordmann P. Further proofs of concept for the Carba NP test. Antimicrob. Agents Chemother. 2014, 58:1269.
6. Ellington M.J., Kistler J., Livermore D.M., Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J. Antimicrob. Chemother. 2007, 59:321-322.
7. Emerson J., Rosenfeld M., McNamara S., Ramsey B., Gibson R.L. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr. Pulmonol. 2002, 34:91-100.
8. Giske C.G., Rylander M., Kronvall G. VIM-4 in a carbapenem-resistant strain of Pseudomonas aeruginosa isolated in Sweden. Antimicrob. Agents Chemother. 2003, 47:3034-3035.
9. Hong S.S., Kim K., Huh J.Y., Jung B., Kang M.S., Hong S.G. Multiplex PCR for rapid detection of genes encoding class A carbapenemases. Ann. Lab. Med. 2012, 32:359-361.
10. Hujer K.M., Hujer A.M., Hulten E.A., Bajaksouzian S., Adams J.M., Donskey C.J., Ecker D.J., Massire C., Eshoo M.W., Sampath R., Thomson J.M., Rather P.N., Craft D.W., Fishbain J.T., Ewell A.J., Jacobs M.R., Paterson D.L., Bonomo R.A. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob. Agents Chemother. 2006, 50:4114-4123.
11. Kidd T.J., Ramsay K.A., Hu H., Marks G.B., Wainwright C.E., Bye P.T., Elkins M.R., Robinson P.J., Rose B.R., Wilson J.W., Grimwood K., Bell S.C., Group, A.C.I. Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. Eur. Respir. J. 2013, 41:1091-1100.
12. Lee K., Chong Y., Shin H.B., Kim Y.A., Yong D., Yum J.H. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect. 2001, 7:88-91.
13. Lee K., Lim Y.S., Yong D., Yum J.H., Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 2003, 41:4623-4629.
14. Llanes C., Pourcel C., Richardot C., Plesiat P., Fichant G., Cavallo J.D., Merens A., Group, G.S. Diversity of beta-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study. J. Antimicrob. Chemother. 2013, 68:1763-1771.
15. Monteiro J., Widen R.H., Pignatari A.C., Kubasek C., Silbert S. Rapid detection of carbapenemase genes by multiplex real-time PCR. J. Antimicrob. Chemother. 2012, 67:906-909.
16. Pasteran F., Veliz O., Faccone D., Guerriero L., Rapoport M., Mendez T., Corso A. A simple test for the detection of KPC and metallo-beta-lactamase carbapenemase-producing Pseudomonas aeruginosa isolates with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin. Microbiol. Infect. 2011, 17:1438-1441.
17. Pitout J.D., Gregson D.B., Poirel L., McClure J.A., Le P., Church D.L. Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large centralized laboratory. J. Clin. Microbiol. 2005, 43:3129-3135.
18. Poirel L., Walsh T.R., Cuvillier V., Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 2011, 70:119-123.
19. Pollini S., Fiscarelli E., Mugnaioli C., Di Pilato V., Ricciotti G., Neri A.S., Rossolini G.M. Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-beta-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype. Clin. Microbiol. Infect. 2011, 17:1272-1275.
20. Smith E.E., Buckley D.G., Wu Z., Saenphimmachak C., Hoffman L.R., D'Argenio D.A., Miller S.I., Ramsey B.W., Speert D.P., Moskowitz S.M., Burns J.L., Kaul R., Olson M.V. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:8487-8492.
21. Tai A.S., Kidd T.J., Whiley D.M., Ramsay K.A., Buckley C., Bell S.C., Group, A.C.I. Molecular surveillance for carbapenemase genes in carbapenem-resistant Pseudomonas aeruginosa in Australian patients with cystic fibrosis. Pathology 2015, 47:156-160.
22. Tijet N., Boyd D., Patel S.N., Mulvey M.R., Melano R.G. Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2013, 57:4578-4580.
23. Tijet N., Boyd D., Patel S.N., Mulvey M.R., Melano R.G. Reply to "further proofs of concept for the Carba NP test". Antimicrob. Agents Chemother. 2014, 58:1270.
24. van der Bij A.K., Mol M., van Westreenen M., Goessens W.H., Pitout J.D. The laboratory diagnosis of Pseudomonas aeruginosa that produce metallo-beta-lactamases in a Dutch tertiary care centre. Scand. J. Infect. Dis. 2011, 43:596-602.
25. Walsh T.R. Emerging carbapenemases: a global perspective. Int. J. Antimicrob. Agents 2010, 36(Suppl. 3):S8-S14.
26. Walsh T.R., Bolmstrom A., Qwarnstrom A., Gales A. Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing. J. Clin. Microbiol. 2002, 40:2755-2759.
27. Walsh T.R., Toleman M.A., Poirel L., Nordmann P. Metallo-beta-lactamases: the quiet before the storm?. Clin. Microbiol. Rev. 2005, 18:306-325.
28. Woodford N., Turton J.F., Livermore D.M. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 2011, 35:736-755.
29. Yan J.J., Hsueh P.R., Ko W.C., Luh K.T., Tsai S.H., Wu H.M., Wu J.J. Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother. 2001, 45:2224-2228.
30. Zemanick E.T., Emerson J., Thompson V., McNamara S., Morgan W., Gibson R.L., Rosenfeld M., the E.S.G. Clinical outcomes after initial Pseudomonas acquisition in cystic fibrosis. Pediatr. Pulmonol. 2015, 50:42-48.